How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Wegovy

Claim This Podcast

by Inception Point AI

3.5(2 reviews)

116 episodes

Updated Bi-weekly

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Authority

Beta

FairBased on show quality, social media presence, reviews, charts, and more

Quality89

Social0

YouTube0

Engagement30

Learn more

Podcast Overview

This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding for anyone considering Wegovy as a weight management solution. This content was created in partnership and with the help of Artificial Intelligence AI.

Language

🇺🇲

Publishing Since

6/4/2024

Visit Website View on Apple Podcasts RSS Feed

🇺🇸 Charts #3

Outreach generated

Apple 142

Spotify 827

Instant mention tracking

Perfect fit!

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

Podcast Authority

Beta

FairBased on show quality, social media presence, reviews, charts, and more

Quality89

Social0

YouTube0

Engagement30

Learn more

Excellent Areas

Good Performance

Growth Opportunities

excellent

Episode Length

6 minutes

Performing excellently!

good

Publishing Consistency

Every 10 days

Recommendations available

Unlock the full report to see detailed tips

poor

Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

• YouTube presence analysis
• Social media reach metrics
• RSS compliance scoring
• Podcast 2.0 features
• Technical standards

What's Included in Your Full Report

Detailed Analytics

Complete breakdown of all 19 authority metrics
Personalized recommendations for each metric
Industry benchmarks and comparisons
Technical RSS feed analysis and compliance scoring

Growth Strategies

Step-by-step action plans for improvement
Quick wins to boost your score immediately
Pro tips from successful podcasters

Get your free podcast insights report

See how your show performs across every key metric

Instant delivery

No spam

Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

3 verified contact emails on file for Wegovy

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

Episode thumbnail for Wegovy Oral Pill Reshapes Obesity Treatment: Three Million Prescriptions, Supply Shortages, and Expanding Cardiovascular Benefits

July 4, 2026

Wegovy Oral Pill Reshapes Obesity Treatment: Three Million Prescriptions, Supply Shortages, and Expanding Cardiovascular Benefits

# SEO-Friendly Podcast Episode Description ## Wegovy Reaches 3 Million Prescriptions: The Weight Loss Revolution Reshaping Healthcare **Episode Summary:** Wegovy oral medication has reached a stunning milestone: **3 million prescriptions filled worldwide**—approximately one every five seconds. In this comprehensive episode, we explore how Novo Nordisk's semaglutide has evolved from a diabetes treatment into a transformative force reshaping medicine, society, and healthcare economics. ### What You'll Learn: **💊 The Wegovy Phenomenon:** - New clinical data from the 2026 American Diabetes Association scientific sessions - How the oral pill version is outperforming injectable formulations - Real-world uptake patterns among younger adults and primary care settings **❤️ Cardiovascular Benefits Beyond Weight Loss:** - Extended follow-up data showing heart attack and stroke risk reduction - Why cardiologists are debating whether Wegovy is actually a heart medicine - Pending FDA and EU regulatory reviews for expanded cardiovascular indications **⚠️ Supply Challenges & Side Effects:** - Pharmacy shortages across Europe and North America - Common and serious side effects: nausea, pancreatitis, bowel obstruction - Mental health concerns: depression, suicidal thoughts, and regulatory scrutiny **💰 Cost, Coverage & Access Inequities:** - Uneven insurance coverage and Medicare expansion debates - Global health disparities: wealthy nations vs. low-income countries - Counterfeit medication warnings and unregulated online sources **🌍 Cultural & Economic Impact:** - Novo Nordisk's market dominance and the pharmaceutical "obesity arms race" - Fashion industry adaptations and workplace wellness programs - "Ozempic face" concerns and rising demand for plastic surgery consultations **🔬 Long-Term Questions:** - Weight regain when stopping treatment: Is lifelong medication necessary? - Pediatric use in teenagers: Promise or peril? - Sustainability of benefits over 5-10+ years ### Keywords: Wegovy, oral semaglutide, weight loss medication, obesity treatment, cardiovascular benefits, Novo Nordisk, diabetes medication, prescription trends, healthcare innovation, pharmaceutical breakthrough, weight management, metabolic health **Perfect for:** Healthcare professionals, patients considering weight loss medication, public health advocates, and anyone following the obesity treatment revolution. --- *This episode examines how Wegovy is forcing society to confront obesity as a treatable medical condition rather than a moral failing—and what that means for the future of healthcare worldwide.* Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai

June 27, 2026

Wegovy Oral Pill Launches in 2026 as Medicare Bridge Program Expands Access and Affordability

# SEO-Friendly Podcast Episode Description ## Wegovy 2026: Medicare Bridge Program, Oral Pills, and the Battle Over Weight Loss Drug Coverage Pull up a chair for this deep dive into **Wegovy's transformation from weight loss medication to healthcare policy battleground**. This episode unpacks the seismic shifts happening right now around **GLP-1 drugs, Medicare coverage, and obesity treatment access**. **What You'll Learn:** 🔹 **New Wegovy Formulations** – The oral pill launched in January 2026, plus a 7.2mg high-dose injection under FDA review (triple the original strength) 🔹 **Medicare GLP-1 Bridge Program** – Starting July 1, 2026, eligible Medicare Part D beneficiaries can access Wegovy for a flat $50 monthly copay through this temporary demonstration program running through 2027 🔹 **Wegovy Pricing Updates** – Current list price of $1,350/month dropping to approximately $675 in 2027, while CVS offers $149 cash prices with vouchers and $25 copays with manufacturer coupons 🔹 **Employer Coverage Pullback** – Why many companies are restricting GLP-1 weight loss drug coverage despite oral options, with net costs still reaching $569-$664 per member monthly 🔹 **CVS MinuteClinic Expansion** – $49 telehealth visits for Wegovy prescriptions and pharmacy support for the Medicare Bridge program 🔹 **Clinical Efficacy Data** – Oral semaglutide 25mg produces 16.6% average weight loss over 64 weeks; injectable formulations show 12-15% reductions over 70 weeks 🔹 **Cardiovascular Benefits** – FDA-approved indication for reducing heart attack and stroke risk in high-risk obesity patients, plus emerging cancer prevention research This episode examines the **intersection of pharmaceutical innovation, health insurance policy, and chronic disease treatment**, exploring whether America's healthcare system will treat obesity with the same seriousness as hypertension or high cholesterol. **Perfect for:** Healthcare professionals, policy analysts, Medicare beneficiaries, patients considering weight loss medications, employers managing benefits, and anyone tracking the **semaglutide revolution** reshaping modern medicine. **Keywords:** Wegovy, GLP-1 drugs, Medicare Bridge Program, oral semaglutide, weight loss medication coverage, Novo Nordisk, obesity treatment, CVS MinuteClinic, healthcare policy 2026 Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai

June 23, 2026

Wegovy High Dose Approved: What You Need to Know About Pricing, Effectiveness, and New Weight Loss Alternatives

# SEO-Friendly Podcast Episode Description ## Wegovy High Dose Approved: New 7.2mg Weight Loss Drug, Pricing, Cancer Research & What You Need to Know in 2026 Join health journalist Alexandra Reeves as she unpacks the latest developments in the Wegovy weight loss medication story, including the FDA's approval of Wegovy HD (high dose) at 7.2mg for long-term obesity treatment. **In this episode, you'll discover:** ✅ **NEW: Wegovy High Dose (7.2mg)** – How the FDA-approved higher dose compares to the original 2.4mg formulation and who qualifies for intensified treatment 💰 **Wegovy Cost & Savings in 2026** – Current pricing ($1,349/month list price), the NovoCare $499 self-pay program, insurance coverage details, and Medicare Part D restrictions 📊 **Real Weight Loss Results** – Clinical trial data showing 15% average weight loss with Wegovy vs. 20% with competitor Zepbound (tirzepatide), based on University of Georgia research comparing 14,000+ patients 🔬 **Wegovy Beyond Weight Loss** – Emerging cancer risk reduction research, liver disease treatment (metabolic dysfunction-associated steatohepatitis), and cardiovascular benefits highlighted by PBS NewsHour ⚠️ **What Patients Need to Know** – Managing side effects, understanding supply issues, navigating compounding pharmacy confusion, and setting realistic expectations 🔮 **The Future: Retatrutide** – Preview of the next-generation triple-agonist showing 30% weight loss (70 lbs average) in Phase 2 trials Whether you're currently taking Wegovy, considering GLP-1 medications for weight loss, or simply want to understand the obesity treatment revolution, this episode provides evidence-based insights into personalized weight loss medicine. **Keywords:** Wegovy, Wegovy high dose, GLP-1 weight loss drugs, semaglutide, obesity medication cost, Wegovy vs Zepbound, weight loss injection, Novo Nordisk, FDA approval 2026 Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai

116 total episodes available

Recent guests on Wegovy

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Alexandra Reeves

Guest

See every guest on Wegovy

Similar Podcasts

Discover related shows you might enjoy

GLP-1 Hub: Support, Community, and Weight Loss

Ana Reisdorf, MS, RD

Game-Changing Health

Gianna Beasley

Biceps After Babies Radio

Amber Brueseke

Well Beyond 40

JJ Virgin

Drop The Weight with Elizabeth McGann

Elizabeth McGann

Fat Science

Dr Emily Cooper

The Mel Robbins Podcast

Mel Robbins

Lifespan with Dr. David Sinclair

Lifespan Communications LLC

The Peter Attia Drive

Peter Attia, MD

The Diary Of A CEO with Steven Bartlett

DOAC

GLP-1 Tribe

Eric Eden

How To Fail With Elizabeth Day

Elizabeth Day and Sony Music Entertainment

Michelle Obama: The Light Podcast

Higher Ground

The Fat Doctor Podcast

Dr Asher Larmie

Apple News Today

Apple News

Deep-dive analytics for Wegovy

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Wegovy?: This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding for anyone considering Wegovy as a weight management solution.

This content was created in partnership and with the help of Artificial Intelligence AI.
How often does this podcast release new episodes?: This podcast updates bi-weekly.
Where can I listen to this podcast?: This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.